A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice.
Bleeding, Thrombosis and Vascular Biology,
[S. l.], v. 1, n. 2, 2022. DOI:
10.4081/btvb.2022.19. DisponÃvel em:
https://www.btvb.org/btvb/article/view/19. Acesso em: 29 jul. 2025.